Altered intestinal functions and increased local inflammation in insulin-resistant obese subjects: A gene-expression profile analysis

BMC Gastroenterology

Volumn 15, Issue 1, 2015, Pages

  Veilleux, Alain ^a   Mayeur, Sylvain ^a   Bérubé, Jean Christophe ^b   Beaulieu, Jean François ^c,d   Tremblay, Eric ^c   Hould, Frédéric Simon ^b,e   Bossé, Yohan ^b,e   Richard, Denis ^b,e,f   Levy, Emile ^a,g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d Chaires de recherche du Canada   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^g Chaire de Recherche Merck Frosst/IRSC Research Chair on Obesity ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BETA GALACTOSIDASE; BETA MICROSEMINOPROTEIN; CALGRANULIN A; CALGRANULIN B; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 2; CYCLOOXYGENASE 2; ELASTASE; GAMMA INTERFERON; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE TRANSPORTER 3; GLUTATHIONE PEROXIDASE 8; HLA A ANTIGEN; HUMANIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LACTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MATRILYSIN; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MUCIN 2; MUCIN 5AC; MUCIN 6; PEPSINOGEN; PROTEIN C FOS; PROTEIN C JUN; TRIACYLGLYCEROL LIPASE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; BETA-MICROSEMINOPROTEIN; HUMANIN LIKE-1 PROTEIN, HUMAN; MESSENGER RNA; PROSTATIC SECRETORY PROTEIN; PROTEIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTION; ENDOCRINE SYSTEM; EXTRACELLULAR MATRIX; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GIP GENE; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE FUNCTION; LIPID ANALYSIS; MALE; METABOLIC DISORDER; MICROARRAY ANALYSIS; MSMB GENE; MTRNR2L1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; UPREGULATION; CACO-2 CELL LINE; DUODENUM; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; CACO-2 CELLS; DUODENUM; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MICROARRAY ANALYSIS; OBESITY; OXIDATIVE STRESS; PROSTATIC SECRETORY PROTEINS; PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84941622691     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-015-0342-y     Document Type: Article

References (43)

1. Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006;26:1357-63.
2. Marcil V, Peretti N, Delvin E, Levy E. Digestive and absorptive processes of lipids. Gastroentérologie Clin Biol. 2004;28:1257-66.
3. Haidari M, Leung N, Mahbub F, Uffelman KD, Kohen-Avramoglu R, Lewis GF, et al. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem. 2002;277:31646-55.
4. Vine DF, Takechi R, Russell JC, Proctor SD. Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome. Atherosclerosis. 2007;190:282-90.
5. Zoltowska M, Ziv E, Delvin E, Sinnett D, Kalman R, Garofalo C, et al. Cellular aspects of intestinal lipoprotein assembly in psammomys obesus a model of insulin resistance and type 2. Diabetes. 2003;52:2539-45.
6. Adeli K, Lewis GF. Intestinal lipoprotein overproduction in insulin-resistant states. Curr Opin Lipidol. 2008;19:221-8.
7. Lewis GF, Naples M, Uffelman K, Leung N, Szeto L, Adeli K. Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters. Endocrinology. 2004;145:5006-12.
8. Lewis GF, Uffelman K, Naples M, Szeto L, Haidari M, Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology. 2005;146:247-55.
9. Federico LM, Naples M, Taylor D, Adeli K. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-Fed hamster intestine. Diabetes. 2006;55:1316-26.
10. Veilleux A, Grenier E, Marceau P, Carpentier AC, Richard D, Levy E. Intestinal lipid handling: evidence and implication of insulin signaling abnormalities in human obese subjects. Arterioscler Thromb Vasc Biol. 2014;34:644-53.
11. Couture P, Tremblay AJ, Kelly I, Lemelin V, Droit A, Lamarche B. Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance. J Lipid Res. 2014;55:128-37.
12. Phillips C, Mullan K, Owens D, Tomkin GH. Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition. Atherosclerosis. 2006;187:57-64.
13. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis. 2001;154:229-36.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
15. Beaulieu JF, Quaroni A. Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells. Biochem J. 1991;280(Pt 3):599-608.
16. Denis MC, Furtos A, Dudonné S, Montoudis A, Garofalo C, Desjardins Y, et al. Apple peel polyphenols and their beneficial actions on oxidative stress and inflammation. PLoS One. 2013;8, e53725.
17. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostat Oxf Engl. 2003;4:249-64.
18. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116-21.
19. Whyte L, Huang Y-Y, Torres K, Mehta RG. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007;67:12007-17.
20. Smith LK, Tandon A, Shah RR, Mav D, Scoltock AB, Cidlowski JA. Deep sequencing identification of novel glucocorticoid-responsive miRNAs in apoptotic primary lymphocytes. PLoS ONE. 2013;8, e78316.
21. Courtois F, Seidman EG, Delvin E, Asselin C, Bernotti S, Ledoux M, et al. Membrane peroxidation by lipopolysaccharide and iron-ascorbate adversely affects Caco-2 cell function: beneficial role of butyric acid. Am J Clin Nutr. 2003;77:744-50.
22. Bodzioch M, Lapicka-Bodzioch K, Zapala B, Kamysz W, Kiec-Wilk B, Dembinska-Kiec A. Evidence for potential functionality of nuclearly-encoded humanin isoforms. Genomics. 2009;94:247-56.
23. Sutcliffe S, De Marzo AM, Sfanos KS, Laurence M. MSMB variation and prostate cancer risk: clues towards a possible fungal etiology. Prostate. 2014;74:569-78.
24. Filz HP. Insulin sensitizer. A new therapy option for type 2 diabetic patients]. MMW Fortschr Med. 2000;142:31-3.
25. Levy E, Spahis S, Ziv E, Marette A, Elchebly M, Lambert M, et al. Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids. Diabetologia. 2006;49:1937-45.
26. Qin B, Qiu W, Avramoglu RK, Adeli K. Tumor necrosis factor-aα induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes. 2007;56:450-61.
27. Duez H, Lamarche B, Valéro R, Pavlic M, Proctor S, Xiao C, et al. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans. Circulation. 2008;117:2369-76.
28. Johansson MEV, Sjövall H, Hansson GC. The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol. 2013;10:352-61.
29. Daft J, Lorenz R. Antimicrobial peptide and mucin expression differ between the diabetic NOD mouse and non-diabetic NOR mouse (650.16). FASEB J. 2014;28(1 Supplement):650-16.
30. Anhe FF, Roy D, Pilon G, Dudonne S, Matamoros S, Varin TV, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64(6):872-83.
31. Baus-Loncar M, Lubka M, Pusch CM, Otto WR, Poulsom R, Blin N. Cytokine regulation of the trefoil factor family binding protein GKN2 (GDDR/TFIZ1/blottin) in human gastrointestinal epithelial cells. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2007;20:193-204.
32. Tomkin GH, Ardill J, Lafferty H, Darragh A. Vasoactive intestinal polypeptide in obesity. Int J Obes. 1983;7:153-60.
33. Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. 2012;30:49-59.
34. Deng T, Lyon CJ, Minze LJ, Lin J, Zou J, Liu JZ, et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab. 2013;17:411-22.
35. Ahrén B. Incretin dysfunction in type 2 diabetes: clinical impact and future perspectives. Diabetes Metab. 2013;39:195-201.
36. Coon SD, Schwartz JH, Rajendran VM, Jepeal L, Singh SK. Glucose-dependent insulinotropic polypeptide regulates dipeptide absorption in mouse jejunum. Am J Physiol Gastrointest Liver Physiol. 2013;305:G678-684.
37. Belinova L, Kahleova H, Malinska H, Topolcan O, Vrzalova J, Oliyarnyk O, et al. Differential acute postprandial effects of processed meat and isocaloric vegan meals on the gastrointestinal hormone response in subjects suffering from type 2 diabetes and healthy controls: a randomized crossover study. PLoS One. 2014;9, e107561.
38. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes. 2001;50:609-13.
39. Kuliawat R, Klein L, Gong Z, Nicoletta-Gentile M, Nemkal A, Cui L, et al. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell. FASEB J Off Publ Fed Am Soc Exp Biol. 2013;27:4890-8.
40. Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E, et al. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci Off J Soc Neurosci. 2001;21:9235-45.
41. Yen K, Lee C, Mehta H, Cohen P. The emerging role of the mitochondrial-derived peptide humanin in stress resistance. J Mol Endocrinol. 2013;50:R11-9.
42. Zacharias DG, Kim SG, Massat AE, Bachar AR, Oh YK, Herrmann J, et al. Humanin, a cytoprotective peptide, is expressed in carotid atherosclerotic [corrected] plaques in humans. PLoS One. 2012;7, e31065.
43. Hall EH, Crowe SE. Environmental and lifestyle influences on disorders of the large and small intestine: implications for treatment. Dig Dis Basel Switz. 2011;29:249-54.